 Opko Health NASDAQ:OPKs stock had its buy rating reissued by equities research analysts at Piper Sandler in a research report issued to clients and investors on Wednesday, TipRanks reports. They presently have a 3.00 target price on the biotechnology companys stock. Piper Sandlers price target indicates a potential upside of 33.33 from the stocks current ... 